1. Home
  2. ATCH vs PTIX Comparison

ATCH vs PTIX Comparison

Compare ATCH & PTIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATCH
  • PTIX
  • Stock Information
  • Founded
  • ATCH 2022
  • PTIX 1994
  • Country
  • ATCH United States
  • PTIX United States
  • Employees
  • ATCH N/A
  • PTIX N/A
  • Industry
  • ATCH
  • PTIX Biotechnology: Pharmaceutical Preparations
  • Sector
  • ATCH
  • PTIX Health Care
  • Exchange
  • ATCH Nasdaq
  • PTIX Nasdaq
  • Market Cap
  • ATCH 3.0M
  • PTIX 3.3M
  • IPO Year
  • ATCH N/A
  • PTIX 2016
  • Fundamental
  • Price
  • ATCH $0.19
  • PTIX $3.83
  • Analyst Decision
  • ATCH
  • PTIX
  • Analyst Count
  • ATCH 0
  • PTIX 0
  • Target Price
  • ATCH N/A
  • PTIX N/A
  • AVG Volume (30 Days)
  • ATCH 2.7M
  • PTIX 210.6K
  • Earning Date
  • ATCH 05-16-2025
  • PTIX 08-13-2025
  • Dividend Yield
  • ATCH N/A
  • PTIX N/A
  • EPS Growth
  • ATCH N/A
  • PTIX N/A
  • EPS
  • ATCH 2.67
  • PTIX N/A
  • Revenue
  • ATCH N/A
  • PTIX N/A
  • Revenue This Year
  • ATCH N/A
  • PTIX N/A
  • Revenue Next Year
  • ATCH N/A
  • PTIX N/A
  • P/E Ratio
  • ATCH $0.07
  • PTIX N/A
  • Revenue Growth
  • ATCH N/A
  • PTIX N/A
  • 52 Week Low
  • ATCH $0.18
  • PTIX $2.35
  • 52 Week High
  • ATCH $66.00
  • PTIX $15.54
  • Technical
  • Relative Strength Index (RSI)
  • ATCH 34.16
  • PTIX 53.21
  • Support Level
  • ATCH $0.18
  • PTIX $3.55
  • Resistance Level
  • ATCH $0.20
  • PTIX $3.97
  • Average True Range (ATR)
  • ATCH 0.02
  • PTIX 0.23
  • MACD
  • ATCH 0.01
  • PTIX 0.04
  • Stochastic Oscillator
  • ATCH 10.53
  • PTIX 81.83

About ATCH AtlasClear Holdings Inc. Common Stock

AtlasClear Holdings Inc is a fintech company. Its goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement, and banking of evolving and innovative financial products with a focus on financial services firms. It is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading. The company believes it is positioned to provide a modern, mission-critical suite of solutions to its clients, enabling them to reduce their transaction costs and compete more effectively in their businesses.

About PTIX Protagenic Therapeutics Inc.

Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's main compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.

Share on Social Networks: